Do DAAs Curb the Long-term Effects of Chronic HCV Infection? Do DAAs Curb the Long-term Effects of Chronic HCV Infection?

After reviewing the evidence, researchers from the Cochrane Hepato-Biliary Group were unable to determine whether long-term treatment with direct-acting antivirals (DAAs) can affect hepatitis C-related morbidity, serious adverse events, health-related quality of life and all-cause mortality.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news